1 results
01/Jan/2014
01/Jan/2014
DOI: 10.1590/S1679-45082014AO2706
Objective : To report the experience in three Brazilian institutions with the use of rituximab in patients with different clinical forms of lupus erythematosus systemic in activity. Methods : The study consisted of a sample of 17 patients with LES, who were already being treated, but that at some stage of the disease showed refractory symptoms. The patients were subdivided into groups according to the clinical manifestation, and the responses for the use of rituximab were rated as complete, partial […]
Keywords: Antibodies, monoclonal/therapeutic use; Lupus erythematosus, systemic/drug therapy